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Rathke’s pouch contains progenitor cells that differentiate into the endocrine cells of the pituitary gland. It gives rise to gonadotrope,
thyrotrope, somatotrope, corticotrope and lactotrope cells in the anterior lobe and the intermediate lobe melanotropes. Pituitary precursor cells
express many members of the Notch signaling pathway including the downstream effector gene Hes1. We hypothesized that Hes1 regulates the
timing of precursor differentiation and cell fate determination. To test this idea, we expressed Hes1 in differentiating pituitary cells and found that
it can inhibit gonadotrope and thyrotrope differentiation. Pituitaries of Hes1 deficient mice have anterior lobe hypoplasia. All cells in the anterior
lobe are specified and differentiate, but an early period of increased cell death and reduced proliferation causes reduced growth, evident as early as
e14.5. In addition, cells within the intermediate lobe differentiate into somatotropes instead of melanotropes. Thus, the Hes1 repressor is essential
for melanotrope specification. These results demonstrate that Notch signaling plays multiple roles in pituitary development, influencing precursor
number, organ size, cell differentiation and ultimately cell fate.
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The pituitary gland controls the release of hormones that
direct growth, metabolism, fertility and the body’s response to
stress. The anterior and intermediate lobes of this gland arise
from a structure known as Rathke’s pouch that invaginates from
the oral ectoderm at embryonic day 8.5 (e8.5) in the mouse
(Burrows et al., 1999; Zhu and Rosenfeld, 2004). Before birth, a
cascade of signaling events activates transcription factors that
serve to specify the five cell types of the anterior pituitary in a
temporally discrete manner. The order of appearance of the fully
differentiated cell types in rodents is corticotropes, thyrotropes,
somatotropes, lactotropes and gonadotropes that secrete adre-
nocorticotropic hormone (ACTH), thyroid-stimulating hormone
(TSH), growth hormone (GH), prolactin (PRL), and gonado-
tropins (FSH and LH), respectively. The intermediate lobe is
composed of melanotropes that secrete melanocyte stimulating
hormone (MSH).⁎ Corresponding author. Present address: University of Illinois at Urbana
Champaign, 524 Burrill Hall; 407 South Goodwin Avenue, Urbana, IL 61801,
USA. Fax: +1 217 333 1133.
E-mail address: raetzman@life.uiuc.edu (L.T. Raetzman).
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doi:10.1016/j.ydbio.2006.11.010We reported that many members of the Notch signaling
pathway are expressed in the developing pituitary gland and
hypothesized that Notch signaling regulates the transition from
proliferation to differentiation (Raetzman et al., 2004). Notch
is an evolutionarily conserved signaling system first identified
in Drosophila. The transmembrane receptor Notch interacts
with its ligand (Delta/Jagged) on a neighboring cell, resulting
in the cleavage of the Notch intracellular domain (NICD),
which then binds to Rbpsuh. This complex translocates to the
nucleus and activates the expression of transcriptional
repressors encoded by the Hes and Hey genes. Hes genes
classically function by inhibiting the transcription of bHLH
genes that normally promote cellular differentiation. In the
pituitary, there is a temporal and dorsal–ventral restriction of
Notch receptors and ligands during development (Raetzman et
al., 2004). The Notch2 and Notch3 receptors and Hes1 are
expressed in Rathke’s pouch progenitor cells, but are excluded
from differentiating progenitors.
Proper expression of Hes1 is essential for the development
of many organs. In Hes1 null mice, the pancreas is hypoplastic
due to premature precursor differentiation (Jensen et al., 2000)
and the biliary epithelium undergoes cell fate conversion to
pancreatic tissue (Apelqvist et al., 1999; Sumazaki et al.,
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NeuroD and Math1 expression concomitant with premature
hormone expression (Jensen et al., 2000). Muscle precursor
differentiation is blocked by Hes1 mediated repression of
MyoD (Kuroda et al., 1999). Notch signaling through Hes1
can also have a specific influence on endocrine cell selection.
In lung development, neuroendocrine cells express Notch
ligands and inhibit Clara cells from becoming neuroendocrine
cells by activating Notch receptors and Hes genes (Ito et al.,
2000). Intestinal lineage specification from crypt cells is also
reliant on Notch signaling. Inhibition of Notch signaling by
blocking receptor cleavage or by deleting Hes1 causes goblet
and enteroendocrine cells to be formed preferentially, the other
lineages are lost and there is overexpression of Ngn3 (Jensen
et al., 2000; Wong et al., 2004). Ngn3 is necessary cell
autonomously to promote enteroendocrine cell differentiation
(Jenny et al., 2002). Taken together, these studies highlight a
common theme in endocrine development, which is that
Notch signaling represses endocrine cell development from
undifferentiated precursors and/or from other differentiated
cells.
To determine if Notch signaling mediates the transition from
pituitary precursor proliferation to differentiation or influences
the specification hormone producing cell types, we undertook a
gain and loss of function analysis of Hes1 in pituitary
organogenesis. We demonstrate that persistent expression of
Hes1 in pre-gonadotropes and pre-thyrotropes prevents their
differentiation. Hes1 deficient mice have abnormally small
pituitary glands, due in part to increased cell death and
decreased proliferation. Additionally, the intermediate lobe
melanotropes exhibit a cell fate switch to somatotropes in the
absence of Hes1. These data suggest that Notch signaling
through Hes1 both inhibits pituitary cell differentiation and
promotes melanotrope cell fate.Materials and methods
Transgene construction
To generate the Cga-Hes1 construct, the Hes1 open reading frame (Ishibashi
et al., 1994) was inserted into a pBSK plasmid containing the mouse protamine
intron, splice sites and polyadenylation sequences. A 4.6 kb fragment containing
the mouse α subunit (Cga) promoter and enhancer (Brinkmeier et al., 1998;
Kendall et al., 1994) was used to direct expression to the pre-gonadotropes and
pre-thyrotropes of the anterior pituitary. Restriction enzyme mapping and partial
sequencing were used to verify the identity of the construct. Prior to
microinjection, the construct was released from the vector by a restriction
enzyme digest with KpnI and ClaI.
Generation and genotyping of transgenic mice
The purified insert was microinjected into F2 zygotes from F1 (C57BL/6J X
SJL/J) parents (JAX labs) by the University of Michigan Transgenic Animal
Model Core. Embryos at the two-cell stage were implanted in pseudopregnant CD-
1 females (Charles River) at embryonic day 0.5 (e0.5). For transgenic founder
analysis, 106 embryos were collected at e18.5. Genotyping to identify the presence
of the transgene was conducted using genomic DNA isolated from tail biopsy
samples. Oligonucleotides were designed to amplify a region spanning the Hes1
cDNA and the mouse protamine sequence: 5′ TAACGCAGTGTCACCTTCCA
3′ and 5′ ATCTGCTCCTGCTTTTGCTG 3′. A standard reaction mixture wasused containing the following concentrations of reagents per reaction; primers
12.5 pmol, BSA 5 μg, and Taq 5 U. PCR amplification was conducted for 29
cycles of denaturing at 92 °C for 30 s, annealing at 55 °C for 30 s, and elongating
at 72 °C for 30 s with a final elongation step conducted at 72 °C for 10 min.
Hes1 null mice
Hes1 null mice were previously generated by replacing the first 3 exons of
Hes1, including the bHLH domain, with a neomycin-resistance cassette
(Ishibashi et al., 1995). A breeding colony of Hes1 null heterozygotes was
established at University of Michigan by re-derivation. Embryos resulting
from matings between heterozygote males obtained from Dr. Ryoichiro
Kageyama and C56BL6/J females (Jackson Laboratory) were transferred to
specific pathogen free surrogate mothers. The resulting heterozygote progeny
were intercrossed for the experiments. Genotyping was performed as
previously described (Jensen et al., 2000). Embryos at specific ages were
obtained from Hes1 heterozygote females mated with Hes1 heterozygote
males. All procedures involving the use of mice were approved by the
University of Michigan Committee on the Use and Care of Animals. All
experiments were conducted in accordance with the principles and procedures
outlined in the NIH Guidelines for the Care and Use of Experimental
Animals.
For bromo-deoxyuridine (BrdU) experiments, pregnant mice were injected
intraperitoneally with 0.1 mg/g body weight BrdU 2 h prior to collecting the
fetuses (Nowakowski et al., 1989).
Histology, immunohistochemistry and in situ hybridization
Wild type, Hes1 transgenic and Hes1 null embryos and adult pituitaries
were fixed for 2–24 h in 10% formalin in phosphate buffered saline pH 7.2,
dehydrated, and embedded in paraffin. Sagittal or coronal sections of 6 μmwere
then prepared for immunostaining or in situ hybridization. For transcription
factor immunostaining, slides were boiled in 10 mM citric acid, pH6, for 10 min
and then incubated with the mouse monoclonal LHX3 antibody (1:1000,
C651.6DbHN Developmental Studies Hybridoma Bank, University of Iowa,
Iowa city IA), mouse monoclonal ISL1 (1:600; 40.2D6 DSHB) or rabbit
polyclonal T-PIT (1:600; gift of J. Drouin, Montreal, Canada) which were
diluted using the M.O.M antibody kit (Vector Laboratories) for LHX3 and ISL1
or PBS containing BSA (3%), Tween-20 (0.5%) and normal donkey serum (5%
w/v) for T-PIT as previously described (Raetzman et al., 2002, 2004). The
Perkin-Elmer TSA kit was used for antibody detection. For immunostaining
with Cyclin D2 (1:250, Santa Cruz), Prohormone convertase 2 (1:300;
Chemicon) or bromo-deoxyuridine (BrdU, 1:100; Harlan Sera), the slides
were boiled in citrate (see above) for 5 min. Antibodies were detected with anti-
rabbit-cy2 (1:200, Jackson ImmunoResearch), anti-rabbit-cy3 (1:200, Jackson
ImmunoResearch) or anti-rat TRITC (1:200, Jackson ImmunoResearch),
respectively. All fluorescently stained slides were mounted in an aqueous
mounting media. Antibodies were also used to detect hormones: ACTH (also
recognizes MSH and POMC; 1:1000; DAKO), MSH (1:500; Chemicon), LHβ
(1:1500; National Hormone and Pituitary Program-NHPP), FSHβ (1:1800;
NHPP), GH (1:1000; NHPP), and TSHβ (1:1000; NHPP). Vectastain kits
(Vector Laboratories) were used for signal amplification and the Sigma Fast 3,3-
Diaminobenzidine Tablet Sets (Sigma) were used for antibody detection. Before
mounting in Permount (Fisher), slides were counterstained for 3 min with
methyl green (Vector Laboratories).
Cell death was determined by the TUNEL (Terminal deoxynucleotidyl
Transferase Biotin-dUTP Nick End Labeling) method using the in situ cell death
detection kit (Roche, Indianapolis IN) according to the manufacturer’s
protocol.
For in situ hybridization (ISH), embryos were collected and embedded in
paraffin as they were for immunohistochemistry. Gene expression was detected
using digoxigenin-labeled riboprobes as previously described (Raetzman et al.,
2004). The in situ probes used were Hes1 (Akazawa et al., 1992) and Fgf10
(Bellusci et al., 1997) (a gift from Brigid Hogan, Durham, NC). The Six6 ISH
probe was derived from a sequence verified full-length Six6 clone from a
RIKEN pituitary cDNA library (Carninci et al., 2003). The Six6 clone in pFLCI
was linearized with BamHI and transcribed with T7 polymerase to produce an
antisense probe.
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Hes1 is expressed in the pituitary during development
Many members of the Notch signaling family are expressed
in the pituitary at embryonic day 12.5 (e12.5) (Raetzman et al.,
2004). To define the window of Hes1 expression, we
performed in situ hybridization on sections of mouse embryos
from e10.5 through e18.5. At e10.5, Hes1 expression is
detected throughout most of Rathke’s pouch and the adjacent
ventral diencephalon (Fig. 1A). Hes1 transcripts are localized
in the dorsal and medial aspects of Rathke’s pouch and are
absent in the ventral region of the pouch at e11.5 (Fig. 1B).
This pattern of Hes1 expression corresponds to the area of the
pouch that contains the proliferating, undifferentiated cells
(Ikeda and Yoshimoto, 1991; Ward et al., 2006). Hes1 is
excluded from the ventral aspect of the pituitary that contains
differentiating cells expressing αGSU, the alpha subunit
common to the glycoprotein hormones TSH, LH and FSH
(Japon et al., 1994). By e13.5, Hes1 expression is waning in
Rathke’s pouch and the ventral diencephalon (Fig. 1C) and is
dramatically reduced by e14.5 (Fig. 1D). Hes1 is no longer
detectable in the pituitary or ventral diencephalon at e18.5, at
which time terminal differentiation markers are detectable for
all the hormone producing cell types (Fig. 2A and data not
shown). The expression pattern of Hes1 in the developing
pituitary suggests that Hes1 could have a role in undiffer-
entiated precursor cells, and its expression is extinguished as
pituitary precursors initiate their differentiation into hormone
producing cells (Japon et al., 1994).
Hes1 expression must be silenced for pituitary cell
differentiation to occur
Hes1 expression is spatially and temporally restricted during
pituitary development. To test the hypothesis that Hes1
maintains Rathke’s pouch precursor cells in an undifferentiated
state and that Hes1 expression must be extinguished forFig. 1.Hes1 is expressed in the developing pituitary in a temporally and spatially restr
present in mid-sagittal sections of pituitaries, at e10.5 (A) and e11.5 (B).Hes1 express
time Hes1 is expressed and to force its expression in differentiating cells, transgenic
promoter and enhancer sequences, the Hes1 open reading frame cDNA, and mousedifferentiation to proceed, we created mice that express Hes1
constitutively under the control of the αGSU promoter and
enhancer sequences, Cga (Fig. 1F). This well characterized
promoter confers cell specific and developmentally regulated
expression of a variety of transgenes in pre-gonadotrope and
pre-thyrotrope cells which persists in the corresponding fully
differentiated cells (Charles et al., 2005; Cushman et al., 2001).
It also directs reporter gene expression in Rathke’s pouch and
the rostral tip thyrotropes, but this expression is extinguished
rapidly.
We examined pituitary development e18.5 in six indepen-
dent Hes1 transgenic founder mice. The transgenic mice with
the highest levels of Hes1 expression expressers were identified
by in situ hybridization with a Hes1-specific probe (Figs. 2B,
C). Out of the six founder mice, four expressed detectable levels
of the Hes1 transgene, with the two shown being the highest
expressers. Hes1 transcripts are present in the anterior lobe of
the transgenics but not in non-transgenics at this time because
endogenous Hes1 expression is already extinguished (Fig. 2A).
The lumen of Rathke’s pouch is dysmorphic in all of the
transgenics, but there is no obvious difference in the overall size
of these pituitary glands relative to those of non-transgenic
mice.
The consequence of persistent Hes1 expression on cell
differentiation was examined by immunostaining for hormone
expression. We assessed the presence of gonadotropes and
thyrotropes by expression of the common alpha subunit
(αGSU) and the distinct beta subunits of luteinizing hormone
(LH) and thyroid-stimulating hormone (TSH). In wild-type
pituitaries, αGSU (Fig. 2D) positive cells are readily detectable
in the ventral aspect of the anterior lobe. In contrast, the anterior
lobes of the Hes1 transgenics either lack αGSU positive cells
(Fig. 2E) or only possess a few stained cells (Fig. 2F), indicating
a failure to differentiate. The severity of the dysmorphology
does not necessarily correlate with the degree to which
differentiation is blocked. LHβ (Fig. 2G) and TSHβ (Fig. 2J)
immunoreactive cells are abundant in the anterior lobe of wild-
type pituitaries, however LHβ (Figs. 2H, I) and TSHβ (Figs.icted pattern.Hes1mRNA is detected by in situ hybridization in Rathke's pouch,
ion wanes at e14.5 (C) and is undetectable by e16.5 (D). To increase the length of
mice were generated with a construct (E) containing 4.6 kb of the mouse αGSU
protamine 1 intron and polyadenylation sequences.
Fig. 2. Mis-expression of Hes1 inhibits gonadotrope and thyrotrope differentiation. Coronal sections of pituitaries from e18.5 mice were probed for Hes1 expression
by in situ hybridization. Hes1 in not detected in the anterior lobe of wild-type mice at this time (A), but transcripts are present in two independent, transient transgenic
anterior pituitary lobes (B, C). The α subunit common to the dimeric hormones LH, FSH and TSH is reduced in transgenic (E, F) pituitaries relative to wild-type (D).
Both LHβ and TSHβ are also absent or substantially reduced in Hes1 transgenics (LH H, I; TSH K, L) compared to wild-type (LH G; TSH J).
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that express Hes1 persistently. In contrast, immunostaining for
POMC-derived proteins is identical in the intermediate and
anterior lobes of wild-type and transgenic pituitaries (data not
shown). Taken together, these data demonstrate that Hes1 can
potently inhibit differentiation of gonadotropes and thyrotropes.
A role of Hes1 in pituitary development, then, may be to
prevent Rathke’s pouch precursor cells from differentiating into
hormone producing cells.
Loss of Hes1 prevents proper pituitary gland morphogenesis
To investigate the effect of Hes1 deficiency on pituitary
development, we utilized Hes1 knockout mice (Ishibashi et al.,
1995). This well-characterized null allele lacks the first 3 exons
of the Hes1 gene, which encodes the bHLH domain of HES1.
Hes1 null embryos die just before or at birth, allowing
examination of the morphology of Rathke’s pouch and the
anterior lobe up to that point in wild-type and Hes1 knockoutembryos. At e11.5, the wild-type infundibulum has formed by
evagination of the neural ectoderm and Rathke’s pouch has
fully separated from the oral ectoderm (Fig. 3A). The
infundibulum is smaller than normal and the process of
Rathke’s pouch separation is delayed in the Hes1 mutants
(arrow, Fig. 3E). By e14.5, the separation is complete in Hes1
mutants. The cartilage that underlies the pouch has not formed a
unified structure in mutants (arrow, Fig. 3F), but it has in wild-
type embryos of the same age (Fig. 3B).
Normally, by e14.5, cells have migrated away from
Rathke’s pouch both ventrally and laterally to form the anterior
lobe (Figs. 3B, C). The anterior lobe in Hes1 mutants is smaller
due to reduced expansion laterally (Fig. 3G). At e18.5, the
anterior pituitary is still undersized in Hes1 null embryos (Fig.
3H), and it appears to lack the posterior lobe that is prominent
in wild-type pituitaries (Fig. 3E). These data demonstrate that
the expression of Hes1 in and around Rathke’s pouch is
necessary for generating the correct size of the anterior and
posterior lobe.
Fig. 3. Pituitary size is reduced in Hes1 mutants. Hematoxylin and eosin (H&E) staining reveals the morphology of wild-type (A–D) and Hes1 null (E–H) pituitaries
during development. In e11.5 sagittal sections, the pouch of the Hes1mutant is formed, but has not completely separated from the underlying oral ectoderm (arrow, E)
compared with the wild-type sagittal section (A). At e14.5, wild-type pituitaries have a nearly fused cartilage plate underneath Rathke's pouch (B), but Hes1 mutants
exhibit a large gap between the rostral and caudal aspects of the cartilage (F). Coronal sections at e14.5 demonstrate that the size of the wild-type anterior pituitary (C,
bracket) is substantially greater than the Hes1mutant (G, bracket). This size difference between the wild-type (D, bracket) and Hes1 mutant (H, bracket) is even more
pronounced in coronal sections of e18.5 pituitaries.
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proliferation in Rathke’s pouch
To investigate the mechanism of pituitary hypoplasia in
Hes1 mutant pituitaries, we compared proliferation and cell
death during pituitary organogenesis in wild-type and Hes1
mutant pituitaries. Cells in the dorsal and medial aspects of
Rathke’s pouch are normally highly proliferative at e11.5, as
demonstrated by BrdU labeling and Cyclin D2 expression (Fig.
4A and data not shown). Although dying cells are detectable in
the adjacent mesenchyme, no cell death is occurring in Rathke’s
pouch at e11.5 in normal mice (Fig. 4B). In contrast, Hes1
mutants have fewer cells labeled with the proliferation marker
BrdU (Fig. 4C, white bracket) and numerous dying cells within
Rathke’s pouch (Fig. 4D, white bracket). By e13.5, Cyclin D2
expression in proliferating Rathke’s pouch cells is similar in
wild-type (Fig. 4E) and Hes1 mutant (Fig. 4G) pituitaries.
Additionally, cell death is no longer apparent in either wild-type
(Fig. 4F) or Hes1 mutant (Fig. 4H) Rathke’s pouches at this
time. It is likely that both an early decrease in progenitor cell
proliferation and elevated progenitor cell death contribute to the
smaller pituitary glands of Hes1 mutants.
Pituitary cell death in Hes1 mutants coincides with a loss of
Lhx3 expression
Cell survival during pituitary gland ontogeny is supported
by FGF signaling from the diencephalon and the expression of
the several transcription factors in Rathke’s pouch including
the LIM homeodomain factor LHX3 (Charles et al., 2005;
Ericson et al., 1998; Norlin et al., 2000; Sheng et al., 1996;
Takuma et al., 1998; Treier et al., 1998; Ellsworth, Butts and
Camper, unpublished observation). It is possible that the celldeath observed in Hes1 mutant pituitaries at e11.5 is due to a
decrease in one of these survival cues. At e10.5, the wild-type
pituitary has detectable cell death along the oral ectoderm (Fig.
5A). This zone of death is expanded in the Hes1 null mutant
(Fig. 5B, white bracket) and extends into Rathke’s pouch.
Lhx3 is normally expressed throughout Rathke’s pouch at
e10.5 (Fig. 5C), but expression is absent in Hes1 mutant
pouches in the area where increased cell death is observed
(Fig. 5D, white bracket). The LIM homeodomain transcription
factor, ISL1, exhibits indistinguishable expression patterns in
wild-type (Fig. 5E) and Hes1 mutant (Fig. 5F) Rathke’s
pouches. Likewise, the transcription factor SIX6, which
promotes pituitary precursor proliferation (Li et al., 2002), is
expressed similarly in Hes1 mutants (Fig. 5H) and wild-type
pouches (Fig. 5G) and the ventral diencephalon (Figs. 5G, H,
arrow). This indicates that Hes1 deficiency alters LHX3
expression specifically.
FGFs released from the infundibulum are important for
proliferation and survival of cells within Rathke’s pouch (De
Moerlooze et al., 2000; Ericson et al., 1998; Norlin et al., 2000;
Ohuchi et al., 2000; Takuma et al., 1998). We examined the
expression of Fgf8 and Fgf10 to determine whether the reduced
cell proliferation and increased cell death in Hes1 mutants
resulted from deficiencies in these growth factors. Fgf10
mRNA is detected in the infundibulum in wild-type mice at
e11.5 (Fig. 5I, arrow). The levels and boundaries of Fgf10
expression appear unchanged in Hes1 mutants relative to wild-
type (Fig. 5J, arrow). Similar results were obtained with Fgf8
expression (data not shown). Because Hes1 expression is not
necessary for proper FGF expression in the infundibulum, but it
is required for normal LHX3 expression in Rathke’s pouch, the
hypoplasia characteristic of Hes1 mutants may be intrinsic to
Rathke’s pouch.
Fig. 5. Hes1 is necessary for cell survival and LHX3 expression. Cell death
(A, B) and LHX3 (C, D) and ISL1 (E, F) expression were examined in wild-type
and Hes1 mutant embryos collected at e10.5. Six6 (G, H) and Fgf10 (I, J)
mRNA expression was examined by in situ hybridization on sagittal sections of
e11.5 embryos. At e10.5, wild-type embryos exhibit cell death at the junction
between Rathke's pouch and the attached oral ectoderm (A, green stained cells).
Hes1 mutants have ectopic dying cells in the caudal aspect of Rathke's pouch
(B, white bracket) that corresponds with lack of LHX3 expression (D, white
bracket). Six6 expression in the diencephalon (arrow) and Rathke's pouch is
equivalent in wild-type (G) and Hes1 mutants (H). Fgf10 expression in the
infundibulum (arrow) is similar in wild-type (I) and Hes1 mutants (J).
Fig. 4. Decreased cell proliferation and increased cell death in Rathke's pouch of
Hes1 mutants. Proliferation was assessed by BrdU immunohistochemistry at
e11.5 (A, C) and Cyclin D2 immunohistochemistry at e12.5 (E, G). There is an
area of decreased density of proliferating cells in the Hes1 mutants at e11.5 (C,
white bracket), compared to the wild-type Rathke's pouch, where proliferating
cells are evenly spacing throughout (A). At e12.5, proliferating cells are located
throughout Rathke's pouch of both wild-type (E) and Hes1 mutants (G). Cell
death was detected by the TUNELmethod in sagittal sections of wild-type (B, F)
and Hes1 mutant (D, H) pituitaries. Dying cells are labeled green and all nuclei
are marked blue with DAPI. At e11.5, wild-type pituitaries have no dying cells
within Rathke's pouch, but Hes1 mutants have many dying cells (D, white
bracket). At e12.5, no cell death is detected in Rathke's pouch of wild-type (F) or
Hes1 mutants (H).
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absence of Hes1
Hes1 is necessary to specify enteroendocrine cells during
intestinal organogenesis (Jensen et al., 2000). To determine if
Hes1 has a similar role in the specification of endocrine cell
types in the developing pituitary gland, we examined pituitary
cell differentiation markers at e18.5. Wild-type and Hes1 null
embryos were immunostained with an antibody that recognizes
pro-opiomelanocortin (POMC) and the proteins produced from
differential cleavage: MSH in the intermediate lobe (IL) and
ACTH in the anterior lobe (AL). Wild-type pituitaries havePOMC immunoreactive cells in the IL and AL (Fig. 6A), but
Hes1 null pituitaries only have immunoreactive cells in the
anterior lobe (Fig. 6B). The mutant intermediate lobe is
completely devoid of POMC immunoreactive cells and
POMC mRNA (data not shown), suggesting that Hes1 is
required for melanotropes but not corticotropes. The lack of
melanotropes in Hes1 null mice is confirmed in two ways. An
Fig. 6. Intermediate lobe melanotropes are lost in the absence of Hes1. Coronal
sections of wild-type (A, C, E, G) and Hes1 null (B, D, F, H) pituitaries were
examined at e18.5. An antibody that recognizes POMC derivatives in the
intermediate lobe (IL) and anterior lobe (AL) shows that, in the wild-type
pituitary, the posterior lobe (PL) is devoid of staining whereas the IL and AL
contain many stained cells. In Hes1 mutants, the AL contains POMC stained
cells, but the IL has a dramatic reduction in staining. MSH and PC2
immunoreactivity is apparent in the intermediate lobe of wild-type pituitaries
(C, E, respectively) but not in Hes1 mutants (D, F, respectively). T-PIT
immunoreactivity is similar in wild-type (G) and Hes1 mutant anterior and
intermediate lobes (H).
Fig. 7. Hes1 deficiency causes a cell fate switch from melanotropes to
somatotropes. PIT1 immunoreactive cells are normally detected in the anterior
lobes of wild-typemice from e16.5 through adulthood, as shown at e16.5 (A) and
e18.5 (C). The PIT1 negative intermediate lobe (IL) is denoted with a bracket.
Hes1 mutant mice express PIT1 which becomes expressed in the caudal part
of the intermediate lobe at e16.5 (B, IL in bracket), and PIT1 is expressed
throughout by e18.5 (D, IL in bracket). Additionally, GH is expressed in the
intermediate and anterior lobes ofHes1mutants (F, IL in bracket), but only in the
anterior lobe of wild-type mice (E, IL in bracket). There is no change in TSHβ,
LHβ or αGSU immunostaining between wild-type (G, I, K, respectively) and
Hes1 mutant (H, J, L, respectively) pituitaries at e18.5.
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the IL of wild-type mice (Fig. 6C) but none in Hes1 null mice
(Fig. 6D). Prohormone convertase 2 (PC2), the enzyme that
processes POMC to produce αMSH, is clearly expressed in
wild-type (Fig. 6E) but not mutant IL (Fig. 6F).
To explore the molecular signature of the cells in the
intermediate lobe of Hes1 mutants further, we examined
expression of the T box transcription factor T-PIT (Tbx19) and
the bHLH transcription factor NeuroD1. Both transcription
factors are normally expressed prior to Pomc. TPIT is
necessary for IL cell specification (Pulichino et al., 2003),
and NeuroD1 deficient mice exhibit delayed corticotrope
development (Lamolet et al., 2001). T-PIT expression is
similar in the IL and AL of wild-type (Fig. 6G) and Hes1
Fig. 8. Genetic model of pituitary development and dependence on Hes1. During initial organogenesis, Hes1 is necessary for survival and proliferation of Rathke's
pouch precursors (A). Hes1 is also necessary for intermediate lobe cells to become melanotropes and not PIT1-containing somatotropes (B).
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expression are unchanged in Hes1 mutants at e14.5 (data not
shown). This indicates that the mechanism whereby Hes1
controls melanotrope fate does not involve either T-PIT or
NEUROD1.
Intermediate lobe cells adopt a somatotrope cell fate in Hes1
mutants
The existing IL cells in Hes1 mutants may be committed to
the melanotrope fate, but not express the terminal differentiation
markers MSH and PC2. Alternatively, the cells located in the
Hes1 null IL may have taken on another cell fate. To distinguish
these possibilities, wild-type and Hes1 mutant pituitaries were
immunostained with an antibody to the homeodomain tran-
scription factor PIT1. PIT1 is normally expressed in the anterior
lobe and is necessary for TSH, GH and PRL expression and
lineage specific proliferation of thyrotropes, somatotropes and
lactotropes (Lin et al., 1994; Ward et al., 2006). PIT1 expression
is observed in the AL of wild-type pituitaries at e16.5 (Fig. 7A)
and e18.5 (Fig. 7C). The Hes1 null AL contains ample numbers
of PIT1 positive cells, but PIT1 is aberrantly expressed in the IL
at e16.5 (Fig. 7B, bracket) and at e18.5 (Fig. 7D, bracket).
These data indicate that Hes1 expression in Rathke’s pouch is
necessary to repress PIT1 expression in the IL.
PIT1 is thought to act in combination with other cell type
restricted transcription factors to generate thyrotropes and
lactotropes (Bradford et al., 1997; Charles et al., 2005; Gordon
et al., 1997). Misexpression of PIT1 can be sufficient for GH
expression, however (Dasen et al., 1999). Ectopic PIT1
expression in the IL of the Hes1 null pituitaries also leads to
GH expression (Fig. 7F, bracket), while GH is only expressed in
the anterior lobe of wild-type mice (Fig. 7E, bracket). No other
ectopic hormone expression was detected in the IL of Hes1
mutants (Figs. 7F, H, J, L). The absence of Hes1, therefore,
results in a cell fate change from melanotropes to somatotropes.
Anterior lobe cell specification does not require Hes1
The anterior lobe is substantially smaller in Hes1 mutants,
but it contains all hormone producing cell types. POMC (Fig.
6B) and GH (Fig. 7F) are expressed in a normal pattern in theAL of Hes1 mutants when compared to wild-type pituitaries at
e18.5 (Fig. 6A, Fig. 7E), in spite of their altered expression
within the IL. In addition, similar levels of TSHβ, LHβ and
αGSU immunoreactivity are seen in wild-type (Figs. 7G, I, K,
respectively) and Hes1 mutant (Figs. 7H, J, L, respectively)
pituitaries. To determine whether Hes1 deficiency promotes
premature differentiation of pituitary cells like it does in many
other organ systems, we examined the appearance of hormones
that mark corticotropes, somatotropes, thyrotropes and gonado-
tropes during development. There was no evidence for
consistent, precocious expression of hormone genes in Hes1
mutants (Figs. S1 and S2).
Discussion
Notch signaling through Hes1 is critically important in the
normal development of many organs. A combination of gain
of function and loss of function approaches has proven useful
in deciphering the distinct role Hes1 plays in cell fate
selection. Hes1 may participate in 2 distinct processes:
directing a precursor to remain uncommitted while a daughter
cell differentiates or biasing a precursor pool that usually
generates diverse types of cells towards one particular
differentiated cell fate. We have uncovered a key role for
Hes1 in pituitary cell fate specification (Fig. 8). Hes1 is
normally expressed in the progenitor cells of Rathke’s pouch
and its levels decrease as differentiation proceeds. Constitu-
tive, ectopic expression of Hes1 in developing gonadotropes
and thyrotropes results in dramatic reduction of LH and TSH
production, indicating that Hes1 expression is sufficient to
inhibit differentiation. Besides its role in maintaining pituitary
cells in an undifferentiated state, Hes1 is also required for
adoption of the melanotrope cell fate. The absence of Hes1
results in ectopic somatotrope specification, at the expense of
melanotropes. There are several possible mechanisms for this
cell fate switch. Hes1 may actively promote melanotrope
differentiation and/or suppress Pit1 expression. Alternatively,
somatotropes may form in the intermediate lobe because Hes1
deficiency permits cells to respond to signaling molecules that
stimulate differentiation at a time when Hes1 should be
inhibiting differentiation. By the time the cues are present to
stimulate melanotrope differentiation, the precursor cells may
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hypothesis is consistent with the requirement for Hes1 to
stimulate Rathke’s pouch precursor cell proliferation. The
undersized pituitary gland in Hes1 mutants is caused by a
combination of reduced cell proliferation and increased cell
death. These studies are the first to demonstrate a definitive
role for Notch signaling in pituitary cell fate choices and
organ growth.
Actively dividing progenitor cells line Rathke’s pouch
during the time Hes1 is expressed (Ikeda and Yoshimoto,
1991). These cells cease dividing and migrate to the anterior
lobe before expressing terminal markers of differentiation. The
expression of Hes1 in the same cells that express Notch2 and
Notch3 suggests that Hes1 is a major effector of Notch
signaling in Rathke’s pouch. Hey1 is expressed in the same
cell population as Hes1 (Raetzman et al., 2006), while Hes6
appears to be in differentiating anterior lobe cells (Raetzman et
al., 2004). It is possible that Hes1 and Hey1 have similar roles
such that a significant amount of Notch signaling could occur in
Hes1 mutant pituitaries. Consistent with the idea that Hes1 is
only a part of Notch readout is that Notch2 knockouts are
embryonic lethal by e10.5 (Hamada et al., 1999), but Hes1
knockouts can live until birth. In addition, loss of the pituitary
specific transcription factor Prop1 results in a profound
diminution of Notch2 expression, while Hes1 levels are not
appreciably altered. The consequence of Prop1 loss in both
humans and mice is failure of the Pit1 lineage, which is
composed of somatotropes, lactotropes and thyrotropes (Gage
et al., 1996a,b; Wu et al., 1998). The fact that these cell types are
specified in the Hes1 mutant, but melanotropes are absent,
further indicates that the Prop1 mutant phenotype is unlikely to
involve Hes1, even though Notch2 expression is dramatically
reduced. Taken together, these data indicate that Hes1 performs
an important role in pituitary development, but that other
downstream Notch targets also regulate cell proliferation and
specification.
The function of Hes1 in pituitary development is similar to
its role during neurogenesis. In vertebrates, retinal progenitors
rely on Notch signaling at two stages, first to block neuronal
differentiation and next to direct precursors to produce glia.
Hes1 null retinas contain fewer neurons due to premature
depletion of the precursors (Tomita et al., 1996). Reciprocally,
misexpression of the Notch target Hes1 in the retina inhibits
neural differentiation and promotes production of Müller glial
precursor cells (Bae et al., 2000; Furukawa et al., 2000). The
Notch signal allows retinal progenitors to instructively generate
glia despite the presence of neurogenic signals at the same time
in development. In the pituitary, it is likely that Notch signaling
interacts with other signaling pathways present during the early
stages of development as well.
There are several other signaling pathways that are critical
for early pituitary cell proliferation and specification. Many
members of the Wnt signaling pathway are detected in
embryonic Rathke’s pouches (Douglas et al., 2001). Wnt
appears to act at several different stages of pituitary develop-
ment, influencing proliferation (Kioussi et al., 2002), growth
(Brinkmeier et al., 2003) and shape (Cha et al., 2004).Additionally, the Wnt target β-catenin interacts with Prop1 to
specify the PIT1 lineage: somatotropes, lactotropes and
thyrotropes (Olson et al., 2006). Wnts or LEF1 can increase
the levels of Notch ligands (Ayyanan et al., 2006; Galceran et
al., 2004; Hofmann et al., 2004). Additionally, Hes1 interacts
with the groucho related genes known as transducin-like
enhancer of split (Tle) to function as a co-repressor (Grbavec
and Stifani, 1996; Ju et al., 2004). Notch and Wnt signals are
also integrated to maintain hematopoietic stem cells. As in the
pituitary, Notch is down-regulated as differentiation proceeds
(Duncan et al., 2005). Notch signaling together with Wnt
signaling maintains the cells in an undifferentiated state, while
Wnt signaling alone promotes proliferation and survival. In the
pituitary, it is likely that Wnt and Notch have overlapping roles
in precursor maintenance while also performing distinct
functions.
BMPs and FGFs provide important survival and differentia-
tion cues during early pituitary organogenesis. We propose that
these signaling pathways interact with the Notch pathway in the
pituitary in a manner similar to that described for other organs.
FGF8 and FGF10 are secreted from the diencephalon and are
essential for proliferation and cell survival in Rathke’s pouch
(Ericson et al., 1998; Norlin et al., 2000; Ohuchi et al., 2000;
Takuma et al., 1998). FGFs may enhance Notch signaling in the
pituitary like they do in developing nervous system cells and
pancreatic progenitor cells (Akai et al., 2005; Miralles et al.,
2006; Norgaard et al., 2003; Yoon et al., 2004). BMP signaling
appears to oppose FGF signaling and regulate the choice of
Rathke’s pouch precursors to differentiate into rostral tip
thyrotropes or corticotropes (Ericson et al., 1998). BMPs may
suppress corticotrope differentiation, in part, by augmenting the
inhibitory effects of Notch signaling. This idea is supported by
the observation that BMPs synergize with Notch signaling to
increase the levels of Hes gene expression in developing
osteoblasts (Nobta et al., 2005), myocytes (Dahlqvist et al.,
2003) and endothelial cells (Itoh et al., 2004). BMP4 is
expressed in the diencephalon dorsal to Rathke’s pouch near the
progenitors where it may suppress differentiation, and BMP2 is
expressed in the ventral mesenchyme near the differentiating
cells, where it may promote differentiation. Both of these
processes may be linked with Notch signaling in the pituitary.
This idea is supported by the observation that BMP4 acts with
Notch to inhibit myogenic differentiation while BMP2 induced
osteoblastic differentiation is promoted by Notch signaling.
A common role of Hes1 is to prevent premature differentia-
tion of precursor cells. This is evident in both neurogenesis and
intestinal endocrine cell development (Jensen et al., 2000;
Nakamura et al., 2000). Hes1 functions to repress cell-
patterning genes, and when Hes1 is absent, premature cell
specification occurs. We predicted that we would also observe
precocious hormone expression in the pituitary of Hes1
deficient mice. Surprisingly, there were no consistent changes
in the timing of pituitary hormone gene expression during
development. It is difficult to eliminate the possibility that
premature differentiation is occurring, however. The onset of
hormone gene expression varied by 1 day among individual
mice that were either wild-type or Hes1 mutants, possibly due
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background effects have been observed in analysis of Pax6 and
Prop1 alleles, and this variation could obscure subtle changes in
the timing of differentiation (Bentley et al., 1999; Cushman et
al., 2001; Kioussi, 1999; Vesper et al., 2006). Premature
differentiation could also be missed due to a paucity of markers
for stages leading to terminal differentiation and hormone
production.
Hes1 is necessary for the survival of cells in the caudal aspect
of Rathke’s pouch. The reason why cell death only occurs in the
caudal region is not clear, but it could be due to interaction of
Notch and other signaling pathways. Chordin and Noggin,
potent inhibitors of BMP signaling, are expressed near the
caudal and dorsal aspects of Rathke’s pouch, respectively, and
affect FGF expression and pituitary cell survival (Treier et al.,
1998) (Davis and Camper, unpublished observation). Reduced
FGF signaling causes increased cell death in Rathke’s pouch
(De Moerlooze et al., 2000). There may be a common
mechanism whereby a combination of extracellular FGF signals
and intrinsic Notch signaling establishes a milieu of factors, all
of which are essential for pituitary cell survival. This idea is
supported by the observation that deficiencies in the transcrip-
tion factors Lhx3 or Lhx4 or the combination of both Pitx1 and
Pitx2 causes increased cell death in the pituitary primordium
(Charles et al., 2005; Raetzman et al., 2002) (Ellsworth, Butts,
Camper, unpublished observation). Like Hes1, lack of Lhx4 or
the combination of Pitx1 and Pitx2 also decreases Lhx3
expression levels. Hes1 appears to play a role in cell survival
in other organ systems. For example, Hes1 null duodenal crypt
cells exhibit similar increases in cell death (Jensen et al., 2000),
and Hes1 can repress the initiation of apoptosis in melanoblasts
(Moriyama et al., 2006).
One of the most significant changes observed in the Hes1
mutant pituitaries is a cell fate change from melanotropes to
somatotropes. The scenario is similar in foregut-derived cells
in Hes1 mutants in that biliary epithelial cells are absent, and
pancreatic cells form in their place (Fukuda et al., 2006;
Sumazaki et al., 2004). Thus, Hes1 either actively represses
one cell fate or directs a multi-potential precursor to a specific
fate in multiple organ systems. The cell fate change in Hes1
deficient mice is another example in support of the idea that
the cells in Rathke’s pouch have the potential to differentiate
into hormone producing cells of either the anterior or the
intermediate lobe. Mice lacking the T box transcription factor
T-PIT (TBX19) exhibit ectopic differentiation of gonadotropes
in the intermediate lobe at the expense of POMC expression,
presumably because T-PIT suppresses expression of the
gonadotrope lineage-specific orphan nuclear receptor tran-
scription factor SF1 (Nur5a1) (Pulichino et al., 2003). Hes1
may be required to suppress Pit1 expression in the cells
normally fated to become melanotropes. This suggests that
suppression of lineage specific transcription factor gene
expression may be equally important as activation of gene
expression to produce multiple types of hormone-producing
cells from Rathke’s pouch precursors. Cell fate choices in the
pituitary may be more complicated than a series of binary
choices (Fig. 8).Acknowledgments
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